These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6199555)

  • 1. [Comparison of 2 methods for determining fibrinogen in the blood plasma].
    Butylin IuP; Buniak OA
    Lab Delo; 1984; (1):15-6. PubMed ID: 6199555
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
    Abrignani MG; Novo G; Di Girolamo A; Caruso R; Tantillo R; Braschi A; Braschi GB; Strano A; Novo S
    Cardiologia; 1999 Dec; 44(12):1047-52. PubMed ID: 10687254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of fibrinogen and fibrinogen gene beta148 and beta854 polymorphisms with coronary heart disease.
    Sun AJ; Ma HL; Chen XY; Wang Y; Fang YM; Ma YL; Wang KQ; Zou YZ; Huang W; Ge JB
    Cardiology; 2008; 111(3):167-70. PubMed ID: 18434720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sterol-fibrinogen blood complexes in patients with diabetes mellitus and associated ischemic heart disease].
    Bodnar PN; Donish RM; Buglak NI; Panasiukova OR
    Ter Arkh; 1983; 55(12):78-81. PubMed ID: 6665725
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinogen serum levels in patients with stable coronary artery disease and acute coronary syndrome].
    Gil M; Zarebiński M; Olszewski R; Adamus J
    Pol Merkur Lekarski; 2000 Aug; 9(50):531-2. PubMed ID: 11081317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment.
    Cortellaro M; Cofrancesco E; Boschetti C; Cortellaro F; Mancini M; Mariani M; Paoletti R
    Thromb Haemost; 2000 Apr; 83(4):549-53. PubMed ID: 10780315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'.
    Keavney B; Danesh J; Parish S; Palmer A; Clark S; Youngman L; Delépine M; Lathrop M; Peto R; Collins R
    Int J Epidemiol; 2006 Aug; 35(4):935-43. PubMed ID: 16870675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinogen content in blood of patients with disturbances in the coronary blood circulation].
    Guniia SS; Kiseleva LN
    Lab Delo; 1966; 5():266. PubMed ID: 4168945
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary study on erythrocyte filterability and other hemorrheological parameters in arteriosclerotic vascular disease].
    Pernigotti L; Neirotti M
    Ric Clin Lab; 1983; 13 Suppl 3():423-6. PubMed ID: 6673024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering fibrinogen levels: clinical update. BIP Study Group. Bezafibrate Infarction Prevention.
    Behar S
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S41-3. PubMed ID: 10070817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood fibrinolytic system in health subjects and elderly patients with ischemic heart disease].
    Korkushko OV; Kovalenko AN
    Ter Arkh; 1980; 52(8):15-9. PubMed ID: 7256585
    [No Abstract]   [Full Text] [Related]  

  • 12. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
    Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of the sterol content in fibrinogen as a method of diagnosing the progression of arteriosclerosis].
    Kondrat'eva LG; Vendt VP; Govseeva NN; Solovtsova KM
    Vrach Delo; 1978 Jul; (7):26-8. PubMed ID: 685250
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemostatic function in coronary artery disease (CAD).
    Gupta A; Sikka M; Madan N; Dwidedi S; Rusia U; Sharma S
    Indian J Pathol Microbiol; 1997 Apr; 40(2):133-7. PubMed ID: 9257498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation.
    Jaeger BR; Meiser B; Nagel D; Uberfuhr P; Thiery J; Brandl U; Brückner W; von Scheidt W; Kreuzer E; Steinbeck G; Reichart B; Seidel D
    Circulation; 1997 Nov; 96(9 Suppl):II-154-8. PubMed ID: 9386091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
    Musiał J; Pajak A; Undas A; Kawalec E; Topór-Madry R; Pazucha T; Grzywacz M; Szczeklik A
    Thromb Haemost; 1997 Apr; 77(4):697-700. PubMed ID: 9134645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorheological parameters in coronary artery disease.
    Kesmarky G; Toth K; Habon L; Vajda G; Juricskay I
    Clin Hemorheol Microcirc; 1998 Jul; 18(4):245-51. PubMed ID: 9741664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simplified method for clinical evaluation of the hexoses of fibrinogen].
    Recalcati P; Pagliano F; Rugarli C
    Haematol Lat; 1967; 10(4):395-407. PubMed ID: 5593509
    [No Abstract]   [Full Text] [Related]  

  • 19. [Various indices of blood lipid composition in patients with chronic ischemic heart disease].
    Palamarchuk VI
    Vrach Delo; 1983 Aug; (8):14-7. PubMed ID: 6636672
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma fibrinogen.
    Lowe GD; Rumley A; Mackie IJ
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):430-40. PubMed ID: 15588432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.